1.69
Aprea Therapeutics Inc Aktie (APRE) Neueste Nachrichten
Aprea Reports Positive Early Cancer Trial Results, Maintains Cash Runway Into 2026 - MSN
Full technical analysis of Aprea Therapeutics Inc. stockWall Street Watch & Verified Momentum Watchlists - Newser
Is Aprea Therapeutics Inc. Stock Overbought or Oversold RSI Indicator AnalysisJuly 2025 Movers & Reliable Entry Point Alerts - Newser
How hedge fund analytics apply to Aprea Therapeutics Inc. stockJuly 2025 Intraday Action & Weekly Chart Analysis and Trade Guides - Newser
Aprea Therapeutics Inc. stock retracement – recovery analysisMarket Performance Report & Free Safe Entry Trade Signal Reports - Newser
Analyzing recovery setups for Aprea Therapeutics Inc. investorsQuarterly Market Review & AI Enhanced Execution Alerts - Newser
Multi asset correlation models including Aprea Therapeutics Inc.Quarterly Earnings Summary & Community Consensus Stock Picks - Newser
Long term hold vs stop loss in Aprea Therapeutics Inc.Index Update & Fast Entry High Yield Stock Tips - Newser
Aprea Therapeutics Maintains Buy Rating Amid WEE1i and ATRi Progress - AInvest
Analyzing drawdowns of Aprea Therapeutics Inc. with statistical toolsWeekly Earnings Recap & AI Based Buy/Sell Signal Reports - Newser
Aprea Therapeutics Inc.’s volatility index tracking explainedJuly 2025 EndofMonth & Weekly Momentum Stock Picks - Newser
What’s the recovery path for long term holders of Aprea Therapeutics Inc.July 2025 Breakouts & Detailed Earnings Play Strategies - Newser
Combining price and volume data for Aprea Therapeutics Inc.Weekly Gains Report & Verified Momentum Stock Alerts - Newser
Is Aprea Therapeutics Inc. meeting your algorithmic filter criteriaJuly 2025 Intraday Action & Free Weekly Watchlist of Top Performers - Newser
Aprea Therapeutics 2025 Q2 Earnings Loss Narrows as Net Income Improves 6.7% - AInvest
Aprea Therapeutics Reports Promising Q2 2025 Results - TipRanks
What’s next for Aprea Therapeutics Inc. stock priceMomentum Prediction Based on AI Backtesting - Newser
Real time social sentiment graph for Aprea Therapeutics Inc.Portfolio Risk Distribution Analysis Tool - Newser
Quantitative breakdown of Aprea Therapeutics Inc. recent moveFree Trade Setups With AI Powered Filters - Newser
Is it too late to sell Aprea Therapeutics Inc.Weekly Trend Watch with Market Signals - Newser
How to forecast Aprea Therapeutics Inc. trends using time seriesFree Early Entry Picks Before News Breakout - Newser
Aprea Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Aprea Therapeutics Reports Q2 2025 Financial Results - MSN
Aprea Therapeutics, Inc. SEC 10-Q Report - TradingView
Aprea Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Clinical Update - The Manila Times
Why Aprea Therapeutics Inc. stock attracts strong analyst attentionInsider Strategy for High Conviction Picks - Newser
Published on: 2025-08-11 23:58:33 - Newser
How Aprea Therapeutics Inc. stock performs during market volatilityNeural Network Based Equity Prediction System - Newser
How to interpret RSI for Aprea Therapeutics Inc. stockFree Daily Stock Market Swing Alerts - Newser
Signal strength of Aprea Therapeutics Inc. stock in tech scannersExit Strategy Guide With Risk Control Plan - Newser
Is Aprea Therapeutics Inc. forming a bottoming baseTechnical Trend Forecast for Investors - Newser
Can you recover from losses in Aprea Therapeutics Inc.Rapid Trade Forecast Based on Indicators - Newser
Buy Signal for Aprea Therapeutics Inc. Stock Key Technical Indicators to WatchMomentum Screener with Buy and Sell Areas - Newser
What candlestick patterns are forming on Aprea Therapeutics Inc.Free Early Entry Tips With Low Risk Zone - Newser
Aprea Therapeutics (APRE) to Release Quarterly Earnings on Monday - Defense World
Strategies to average down on Aprea Therapeutics Inc.Swing Reversal Forecast Based on Patterns - Newser
Aprea Therapeutics APRE 2025Q2 Earnings Preview Upside Potential Amid Breakthrough Therapy Designation - AInvest
Key resistance and support levels for Aprea Therapeutics Inc.Buy Opportunity Forecast for Fast Traders - Newser
Aprea Therapeutics Inc expected to post a loss of 74 cents a shareEarnings Preview - TradingView
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):